ASH 43rd (2001)

Drupal spam blocked by CleanTalk.
Title Content type
The Effect of Leukocyte Compatibility on G-CSF Mobilized Granulocyte Transfusions in Infected Neutropenic Cancer Patients. (click for details)
High Dose Chemotherapy (HDC) Followed by Syngeneic Stem Cell Transplantation for Primary AL Amyloidosis Is a Safe and Highly Effective Treatment Modality. (click for details)
Outcome of 21 Patients Undergoing Unrelated Bone Marrow Transplant for Hematologic Malignancies at a Single Institution. (click for details)
Procalcitonin (PCT): A New Marker for Diagnosis of Bacterial and Fungal Infections in Allo and Autotransplanted Pediatric Patients. (click for details)
Long-Term antifungal Prophylaxis in Allogeneic Bone Marrow Transplant Patients: A Multicenter, Randomized Trial of Intravenous/Oral Itraconazole Versus Intravenous/Oral Fluconazole (click for details)
Non-Myeloablative Transplants Using Cyclophosphamide (CY) and Fluadarabine (FL) with G-CSF Stimulated Bone Marrow. (click for details)
Intermittent Intermediate Dose Arabinosilcytosine (ID Ara-C) Preceded by a Fludarabine (FAMP) Minimum Effective Dose and All-Trans Retinoic Acid (ATRA) in Relapsed or Resistant Acute Myeloid Leukaemia (AML). (click for details)
Feasibility of Administering High-Dose Melphalan (HDM) with Autotransplantation in Myeloma Patients on Dialysis. (click for details)
In - Vivo / Ex - Vivo T - Cell Depleted Peripheral Blood Progenitor Cell Transplants : A Single Center Experience of 160 Consecutive Cases Using Three Methodes of T Cell Depletion. (click for details)
100 mg/m2 Melphalan and Repeated Infusions of G-CSF-Mobilized Allogeneic Blood Stem Cells (Microallograft) as Therapy of High-risk Myeloma Relapsing after 1-2 Previous Autografts: High Complete Response Rates in Association with Chronic Graft-Versus-Ho (click for details)


Subscribe to ASH 43rd (2001)